autologous CD19-targeted CAR-T cell therapychimeric antigen receptor T (CAR-T) cell therapymitoxantrone-based reinduction chemotherapyblinatumomabB-cell acute lymphoblastic leukemiaB-ALL
…with relapsed B-ALL after blinatumomab who failed to respond to autologous CD19-targeted CAR-T cell therapy and mitoxantrone-based reinduction chemotherapy. The patient ac…